F. Facchetti

3.3k total citations
89 papers, 2.2k citations indexed

About

F. Facchetti is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, F. Facchetti has authored 89 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 63 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in F. Facchetti's work include Hepatitis B Virus Studies (56 papers), Hepatitis C virus research (54 papers) and Liver Disease Diagnosis and Treatment (44 papers). F. Facchetti is often cited by papers focused on Hepatitis B Virus Studies (56 papers), Hepatitis C virus research (54 papers) and Liver Disease Diagnosis and Treatment (44 papers). F. Facchetti collaborates with scholars based in Italy, United States and France. F. Facchetti's co-authors include Pietro Lampertico, Caterina A. M. La Porta, E. Galmozzi, Mauro Viganò, Massimo Colombo, Angela Gritti, Chiara Cavazzin, Elena Monzani, Fabien Zoulim and Alessandro Loglio and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

F. Facchetti

84 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Facchetti Italy	23	1.3k	1.2k	479	454	274	89	2.2k
Kazuyoshi Ohkawa Japan	29	798 0.6×	1.0k 0.8×	618 1.3×	710 1.6×	526 1.9×	158	2.4k
Karine Poussin France	16	824 0.6×	753 0.6×	478 1.0×	489 1.1×	237 0.9×	26	1.7k
Marc Ringelhan Germany	14	500 0.4×	536 0.5×	588 1.2×	452 1.0×	629 2.3×	25	1.7k
Laurent Mailly France	16	434 0.3×	401 0.3×	732 1.5×	171 0.4×	346 1.3×	25	1.4k
Kouki Nio Japan	16	332 0.2×	427 0.4×	698 1.5×	449 1.0×	171 0.6×	54	1.3k
Kenichi Fukai Japan	24	1.0k 0.8×	1.1k 0.9×	634 1.3×	158 0.3×	52 0.2×	59	1.9k
Takayuki Yakushijin Japan	19	467 0.3×	624 0.5×	217 0.5×	181 0.4×	352 1.3×	64	1.1k
Linda Diehl Germany	25	439 0.3×	461 0.4×	587 1.2×	641 1.4×	1.6k 5.8×	49	2.5k
Abeer A. Bahnassy Egypt	24	450 0.3×	490 0.4×	516 1.1×	501 1.1×	104 0.4×	89	1.6k
Till Krech Germany	28	461 0.3×	493 0.4×	795 1.7×	456 1.0×	141 0.5×	79	1.9k

Countries citing papers authored by F. Facchetti

Since Specialization

Citations

This map shows the geographic impact of F. Facchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Facchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Facchetti more than expected).

Fields of papers citing papers by F. Facchetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Facchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Facchetti. The network helps show where F. Facchetti may publish in the future.

Co-authorship network of co-authors of F. Facchetti

This figure shows the co-authorship network connecting the top 25 collaborators of F. Facchetti. A scholar is included among the top collaborators of F. Facchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Facchetti. F. Facchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salpini, Romina, Elisabetta Degasperi, Lorenzo Piermatteo, et al.. (2025). HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D. Liver International. 45(5). e70094–e70094.

Bert, Nina Le, Apostolos Koffas, Rajneesh Kumar, et al.. (2025). Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases. Journal of Hepatology. 83(6). 1292–1304. 2 indexed citations

Iavarone, Massimo, Riccardo Perbellini, Sara Uceda Renteria, et al.. (2024). ASAP score may predict HCC recurrence after complete radiological response to locoregional treatments. Digestive and Liver Disease. 56. S89–S89. 1 indexed citations

Renteria, Sara Uceda, Elisabetta Degasperi, Marta Borghi, et al.. (2024). Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver International. 44(3). 831–837. 4 indexed citations

Toniutto, Pierluigi, Edmondo Falleti, Sara Cmet, et al.. (2024). Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide. Journal of Hepatology. 81(5). 819–826. 5 indexed citations

Degasperi, Elisabetta, Sara Uceda Renteria, Marta Borghi, et al.. (2023). Pretreatment and on-therapy HDV RNA levels predict response to Bulevirtide monotherapy in HDV compensated cirrhotic patients treated up to 96 weeks. Journal of Hepatology. 78. S1159–S1159. 1 indexed citations

Degasperi, Elisabetta, Sara Uceda Renteria, Marta Borghi, et al.. (2022). Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension. Journal of Hepatology. 77(6). 1525–1531. 42 indexed citations

Chatzigeorgiou, Antonios, Lampros Chrysavgis, Peter Lembessis, et al.. (2020). Circulating cell‐free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients. Journal of Viral Hepatitis. 28(3). 464–474. 6 indexed citations

Loglio, Alessandro, Massimo Iavarone, G. Grossi, et al.. (2018). Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B. Alimentary Pharmacology & Therapeutics. 48(4). 431–439. 5 indexed citations

10.

Galmozzi, E., F. Facchetti, Riccardo Perbellini, & Alessio Aghemo. (2014). High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815. Clinical Microbiology and Infection. 20(11). O936–O938. 3 indexed citations

11.

Viganò, Mauro, Angiola Spinetti, S. Zaltron, et al.. (2014). Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal. Journal of Clinical Virology. 61(4). 600–603. 45 indexed citations

12.

Lampertico, Pietro, Mauro Viganò, G.G. Di Costanzo, et al.. (2012). Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B. Gut. 62(2). 290–298. 83 indexed citations

13.

Lampertico, Pietro, Mauro Viganò, Cristina Cheroni, et al.. (2012). IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen–negative patients with chronic hepatitis B. Hepatology. 57(3). 890–896. 117 indexed citations

14.

Viganò, Mauro, Claudia Vener, Pietro Lampertico, et al.. (2010). Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT. Bone Marrow Transplantation. 46(1). 125–131. 67 indexed citations

15.

Porta, Caterina A. M. La, Elena Monzani, F. Facchetti, & Carla Perego. (2008). Knock down of AQP1 in human endothelial cells and melanoma cancer stem cells changes the organisation of the cytoskeleton. Cancer Research. 68. 3597–3597. 1 indexed citations

16.

Iavarone, Massimo, Pietro Lampertico, Mauro Viganò, et al.. (2008). Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B. Hepatology. 48. 1 indexed citations

17.

Viganò, Mauro, Pietro Lampertico, F. Facchetti, G. Lunghi, & Massimo Colombo. (2008). Failure of adefovir 20 mg to improve suboptimal response in lamivudine‐resistant hepatitis B patients treated with adefovir 10 mg and lamivudine. Journal of Viral Hepatitis. 15(12). 922–924. 2 indexed citations

18.

Facchetti, F., Elena Monzani, Gabriella Cavallini, Ettore Bergamini, & Caterina A. M. La Porta. (2007). Effect of a caloric restriction regimen on the angiogenic capacity of aorta and on the expression of endothelin-1 during ageing. Experimental Gerontology. 42(7). 662–667. 16 indexed citations

19.

Monzani, Elena, F. Facchetti, E. Galmozzi, et al.. (2007). Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. European Journal of Cancer. 43(5). 935–946. 442 indexed citations

20.

Facchetti, F., Elena Monzani, & Caterina A. M. La Porta. (2007). New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies. Recent Patents on Anti-Cancer Drug Discovery. 2(1). 73–78. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact